TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial.

Mehmet A Bilen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.